Given the following molecule represented by the SMILES string: NS(=O)(=O)c1cc(Cl)c(Cl)c(S(N)(=O)=O)c1, and the following genes: ABCB1,ABL1,ADRA1D,ADRA2B,ADRB2,CA12,CA2,CA9,CACNA1H,CDK2,CHRM1,CHRM3,CHRM4,CNR1,CYP1A2,CYP2C19,CYP2C9,CYP2D6,CYP3A4,DRD2,DRD3,DRD4,EGFR,ESR1,FLT1,HRH1,HTR1A,HTR2A,HTR2B,HTR2C,HTR6,KCNH2,KDR,LCK,MCL1,OPRK1,PPARG,PTGS1,SIGMAR1,SLC6A2,SLC6A4, describe whether the molecule is related to one or a few of these genes in clear, simple and accurate English. Explain the relationship between the molecule and the related genes in detail. You can break down by explain the patterns of the molecule, followed by the gene features. Format the output as 'Step 1:', 'Step 2:', etc., with each step focusing on a specific aspect of the molecule's structure or properties. Finally, summarize the related gene names in a list. Limit the reasoning to at most 5 steps. You can stop after summarizing the related gene names. Step 1: The molecule has a complex structure including a nitrogen-containing heterocycle, an oxygen-containing heterocycle, and multiple substituents such as chlorine atoms. This structure suggests it could interact with proteins that have similar functional groups or binding sites.
Step 2: Among the given genes, those encoding receptors (such as ADRA1D, ADRA2B, ADRB2, CHRM1, CHRM3, CHRM4, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR2A, HTR2B, HTR2C, HTR6) and enzymes involved in drug metabolism (like CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4) are potential candidates for interaction due to their involvement in signal transduction and metabolic pathways.
Step 3: The presence of a nitro group (-NO2) in the molecule could indicate a possible interaction with enzymes like CYP2E1, which metabolizes compounds containing nitro groups, though this enzyme is not listed among the provided genes. However, other CYP enzymes listed (CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4) might be relevant if the molecule undergoes phase I metabolism involving oxidation.
Step 4: Given the presence of sulfur-containing functionalities (sulfonates and sulfides), the molecule might interact with transporters that handle organic anions or cations, such as SLC6A2 and SLC6A4, which are involved in the reuptake of neurotransmitters.
Step 5: The overall structure and functional groups suggest the molecule could potentially modulate the activity of G-protein coupled receptors (GPCRs) and ion channels, which are encoded by genes like CHRM1, CHRM3, CHRM4, HRH1, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, and KCNH2.
Summary of Related Genes:
- ADRA1D, ADRA2B, ADRB2
- CHRM1, CHRM3, CHRM4
- DRD2, DRD3, DRD4
- HRH1, HTR1A, HTR2A, HTR2B, HTR2C, HTR6
- KCNH2
- CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4
- SLC6A2, SLC6A4
These genes encode proteins that could directly interact with or be influenced by the described molecule through various mechanisms including receptor activation, enzyme inhibition, or transporter modulation.
